Senators are pushing the bipartisan INSULIN Act of 2026, which would cap insulin costs at $35 a month for insured and uninsured Americans starting 2027.
EURweb on MSN
One Injection Could Replace Daily Insulin for Type 1 Diabetes Patients, Researchers Say
*A gene therapy that may eliminate, or significantly reduce, the need for daily insulin injections is preparing to enter ...
A bipartisan quartet of of senators on Wednesday unveiled legislation to cap the monthly cost of insulin at $35 for patients ...
Advocates expect the young adult population to especially benefit from the bill, since many struggle to get high-quality ...
The FDA approved insulin icodec (Awiqli) as the first once-weekly, long-acting basal insulin for glycemic control in adults ...
Everyday Health on MSN
Do you still need insulin for type 2 diabetes in the Ozempic era?
Learn how GLP-1s are changing type 2 diabetes care, when insulin therapy is still necessary, and the benefits of combining ...
A small device implanted just beneath the skin, roughly the size of a large postage stamp and weighing about two grams, kept ...
Novo Nordisk’s icodec-abae is now approved in the US for type 2 diabetes only, after a prior rejection partly due to concerns about hypoglycemia in type 1 diabetes.
6d
Diabetes advocates cross their fingers as a bipartisan bill revives efforts to lower insulin costs
Two-year-old Bain Brandon has Type 1 diabetes and needs insulin to live. But even with health insurance, the price tag isn’t ...
Read more from STAT contributor Brianna Abbott on the popular vote winner. And STAT’s Amanda Erickson, who edits this very newsletter, has a dispatch on the research our editors chose as the best ...
The FDA approved a once-weekly, long-acting basal insulin for adults with type 2 diabetes as an alternative to daily basal ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results